The stock of Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) has been Reiterated to Overweight by Cantor Fitzgerald in its latest research note that was published on March 16. AUPH has given a price target of $16 by Cantor Fitzgerald, with other Wall Street analysts also giving their reports regarding the stock. RBC Capital Mkts, analysts launched coverage of AUPH stock with a Outperform rating, according to their flash note to investors on February 08. Analysts at H.C. Wainwright are sticking to their Buy recommendation. However, on October 30, they lifted target price for these shares to $12 from $10.Analysts at H.C. Wainwright, made their first call for the stock with a Buy rating, according to a research note that dated back to October 30.
Aurinia’s stock is covered by 6 analyst(s), with 6 of them rating the stock as Buy. It has been deemed to have Strong Buy by none of the analyst(s), none of them have rated it as a Hold while none of them rated it as Sell. The situation was different a month ago when the stock was rated as a Buy by only none analyst(s). none of them rated it as Strong Buy with none of them recommended investors to Hold on to the stock. Meanwhile, none analyst(s) rated it as a Sell. The above data shows that AUPH has an average analyst rating of Buy.
Aurinia Pharmaceuticals Inc., which has current market capitalization of above $468 Million, published its last quarter earnings on June 30, 2019. The company was able to amass $39 Million in revenue that saw a quarterly growth rate of 3.62%. During the last reported quarter of the year, the company also recorded $-0.17 earnings per share (EPS) which is $-0.02 below the $-0.15 estimated by analyst, leading to a surprise factor of -13.33%.
Let us now take a quick look at the stock’s short, medium and long-term indicators. Composite Indicator shows that AUPH stock was rated as a Sell by TrendSpotter. Its short-term indicators reveal that Aurinia has a 20-day average volume of 847007 shares. This has led to the AUPH price forecast being placed as a : 50%Sell on an average basis. In the medium term, however, the AUPH stock has its 50-Day average volume of 607221 shares, with the indicators also rating it as a 100%Sell. Finally, in the long-term, the AUPH stocks have a 100-Day average volume of 523494 shares, with the long-term indicators rating the stock as just 100%Sell.
Looking at the stock’s Technical analysis information over the past 50 days shows that its Raw Stochastic average stood at 0%. This figure is worse than the company’s 20-day Raw Stochastic average which currently stands at 0%. Over the past 20 days, Aurinia’s Stochastic %K stood at 4.61% while its Stochastic %D was revealed to be 4.86%.